Venturi Wealth Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Venturi Wealth Management, LLC

$1.77 Billion
Q3 2024

A detailed history of Venturi Wealth Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Venturi Wealth Management, LLC holds 522 shares of REGN stock, worth $366,365. This represents 0.03% of its overall portfolio holdings.

Number of Shares

522

Previous 517 0.97%

Holding current value

$366,365

Previous $543,000 0.92%

% of portfolio

0.03%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$1024.09 - $1201.76 $5,120 - $6,008	5 Added 0.97%	522 $548,000
Q2 2024 Jul 19, 2024	BUY	$883.2 - $1071.19 $20,313 - $24,637	23 Added 4.66%	517 $543,000
Q1 2024 Apr 23, 2024	SELL	$902.69 - $993.35 $2,708 - $2,980	-3 Reduced 0.6%	494 $475,000
Q4 2023 Jan 23, 2024	BUY	$775.18 - $881.7 $54,262 - $61,719	70 Added 16.39%	497 $436,000
Q3 2023 Nov 02, 2023	SELL	$692.45 - $844.37 $13,849 - $16,887	-20 Reduced 4.47%	427 $351,000
Q2 2023 Jul 24, 2023	BUY	$700.03 - $830.35 $32,901 - $39,026	47 Added 11.75%	447 $321,000
Q1 2023 May 02, 2023	SELL	$680.49 - $826.97 $23,817 - $28,943	-35 Reduced 8.05%	400 $328,000
Q4 2022 Jan 31, 2023	BUY	$705.89 - $766.39 $63,530 - $68,975	90 Added 26.09%	435 $313,000
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $14,923 - $18,832	-26 Reduced 7.01%	345 $237,000
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $117,895 - $158,850	-215 Reduced 36.69%	371 $219,000
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $17,258 - $20,254	-29 Reduced 4.72%	586 $409,000
Q4 2021 Feb 08, 2022	SELL	$543.48 - $670.97 $5,978 - $7,380	-11 Reduced 1.76%	615 $388,000
Q3 2021 Oct 19, 2021	SELL	$574.03 - $680.96 $56,828 - $67,415	-99 Reduced 13.66%	626 $379,000
Q2 2021 Aug 02, 2021	SELL	$472.8 - $558.54 $143,731 - $169,796	-304 Reduced 29.54%	725 $405,000
Q1 2021 Apr 22, 2021	SELL	$446.73 - $548.2 $23,676 - $29,054	-53 Reduced 4.9%	1,029 $487,000
Q4 2020 Jan 28, 2021	SELL	$478.3 - $607.98 $52,134 - $66,269	-109 Reduced 9.15%	1,082 $523,000
Q3 2020 Nov 03, 2020	BUY	$544.75 - $658.21 $312,686 - $377,812	574 Added 93.03%	1,191 $666,000
Q2 2020 Aug 05, 2020	SELL	$493.32 - $643.92 $16,772 - $21,893	-34 Reduced 5.22%	617 $385,000
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $1,344 - $1,977	-4 Reduced 0.61%	651 $318,000
Q4 2019 Jan 27, 2020	SELL	$274.13 - $376.51 $15,351 - $21,084	-56 Reduced 7.88%	655 $246,000
Q3 2019 Oct 29, 2019	BUY	$273.46 - $318.39 $15,040 - $17,511	55 Added 8.38%	711 $197,000
Q2 2019 Aug 07, 2019	BUY	$299.6 - $414.82 $3,595 - $4,977	12 Added 1.86%	656 $205,000
Q1 2019 May 14, 2019	SELL	$372.08 - $439.57 $1,860 - $2,197	-5 Reduced 0.77%	644 $264,000
Q4 2018 Feb 12, 2019	BUY	$335.82 - $403.04 $6,380 - $7,657	19 Added 3.02%	649 $241,000
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $179,298 - $217,343	630 New	630 $234,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Venturi Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Venturi Wealth Management, LLC with notifications on news.

Account

Venturi Wealth Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History